INVESTORS & MEDIA
Corporate Governance
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Jul 01, 2015 |
Director, Chairman of the Board
Trans History: 677
|
Director, Chairman of the Board | Bona fide gift | 414 | -- |
| May 28, 2015 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Bona fide gift | 1,000 | -- |
| Apr 01, 2015 |
Director, Chairman of the Board
Trans History: 677
|
Director, Chairman of the Board | Bona fide gift | 462 | -- |
| Jan 06, 2015 |
Director, Chairman of the Board
Trans History: 677
|
Director, Chairman of the Board | Bona fide gift | 511 | -- |
| Dec 16, 2014 |
Director, President Regeneron Laboratori
Trans History: 581
|
Director, President Regeneron Laboratori | Bona fide gift | 3,264 | -- |
| Dec 16, 2014 |
Director, President Regeneron Laboratori
Trans History: 581
|
Director, President Regeneron Laboratori | Bona fide gift | 3,264 | -- |
| Nov 24, 2014 |
Director
Trans History: 402
|
Director | Bona fide gift | 2,000 | -- |
| Nov 18, 2014 |
SVP Research and Development S
Trans History: 592
|
SVP Research and Development S | Bona fide gift | 250 | -- |
| Nov 17, 2014 |
SVP Administration & Asst Secr
Trans History: 645
|
SVP Administration & Asst Secr | Bona fide gift | 1,930 | -- |
| Nov 17, 2014 |
Director, Chairman of the Board
Trans History: 677
|
Director, Chairman of the Board | Bona fide gift | 24,900 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.